Photo: India Today
Air India Pilot Allowed Woman Friend Inside Cockpit, Case Registered
An Air India pilot allegedly allowed a woman friend inside the cockpit of the flight. The case was registered with the AI and the DCGI, after a cabin crew filed a complaint citing violation of safety norms. The accused pilot also asked the cabin crew to make a welcoming, warm and comfortable arrangement for his woman friend. After the incident, the AI issued a statement and assured strict action.
Tags: DCGI, civil aviation, Air India Flight, Safety Norm Violation
Courtesy: ANI
Photo: First Post
Bharat Biotech Gets Emergency Use Authorization For Intranasal Vaccine Against Covid-19
Bharat Biotech International Ltd (BBIL) on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for its intranasal COVID-19 vaccine, announced Union Health Minister Mansukh Mandaviya. With this, Bharat Biotech's intranasal COVID-19 vaccine will be India's first nasal vaccine for the deadly virus in India. The approval came after the Bharat Biotech completed the third and final trial of the drug, used for… read-more
Tags: Intranasal vaccine, Bharat biotech, Union government, DCGI, EUA
Courtesy: The Free Press Journal
Photo: Deccan Herald
DCGI Official & 1 Other Arrested For Taking Bribe Of Rs 4 Lakh: Delhi
In the National Capital of Delhi, one Drug Controller General of India (DCGI) official was arrested by CBI for allegedly taking a bribe of Rs 4 lakh, on June 21. Along with Joint Drugs Controller (JDC) Eswara Reddy, Dinesh Dua, Director of a Delhi-based private company was also apprehended. The duo was allegedly accepting the bribe to waive off the phase III clinical trial of Insulin Aspart injection.
Tags: Bribe, Eswara Reddy, DCGI, JDC, Dinesh Dua
Courtesy: ANI
Photo: News 18
DCGI Grants EUA For 2 Doses Of ZyCoV-D, COVID Vaccine For Children
The Drugs Controller General of India granted Emergency Use Authorization (EUA) of two doses of ZyCoV-D, a COVID-19 vaccine for children above 12 years old. Manufactured by Zydus Lifesciences limited, the vaccine was used in three doses, for 0,28, and 56 days. However, with the recent approval, ZyCoV-D would now be used in two doses, with a gap of 0-28 days. With this, vaccination time required will be reduced.
Tags: ZyCoV-D Vaccine, Covid-19 Vaccine, DCGI, children, Time Gap
Courtesy: ANI
Photo: The Times Of India
DCGI Approves Covaxin For Children Between 6-12 Year Old, Corbevax For EUA
The Drugs Controller General of India (DCGI) approved the two vaccines Covaxin and Corbevax for children under 12 in India, against COVID-19. While Bharat Biotech's Covaxin has been approved for 6 to12-year-old, Biological E's Corbevax will be used as Emergency Use Authorization (EUA) for 5 to12-year-old kids in India. The approval was based on the Subject Expert Committee's recommendation report, which was prepared as per trials of the… read-more
Tags: Covaxin, covid-19 vaccines, DCGI, Corbevax, children
Courtesy: The Free Press Journal
Photo: Hindustan Times
SEC Recommends Corbevax COVID-19 Vaccine For 5-12 Year Old
The Subject Expert Committee (SEC) or the Drugs Controller General of India (DCGI) recommended the Corbevax COVID-19 vaccine for children between the 5 to 12-year-old age group. On April 21, the government panel said the vaccine is effective in children and has been recommended after trials. Furthermore, the final approval for the emergency use authorization (EUA) of Corbevax would be given by the DCGI soon.
Tags: Corbevax, Covid-19, DCGI, Delhi, children
Courtesy: ANI
Photo: ABP News
Glenmark Launches Nitric Oxide Nasal Spray For COVID-19 Patients In India
Amid COVID-19 pandemic, India is to have Nitric Oxide Nasal Spray, for adults having the infection. Launched on February 9 by Glenmark Pharmaceutical, the spray would be for adults, contracting the virus, with high-risk of progression of the disease. The medicine has been launched under FabiSpray brand in India. In July 2021, Glenmark proposed the nasal Spray, which later got approved by the Drugs Controller Genera of India (DCGI).
Tags: Covid-19, Nasal Spray, glenmark pharmaceuticals, Central Government, DCGI
Courtesy: The Free Press Journal
Photo: Hindustan Times
Human Trials Of mRNA, India's Vaccine Against Omicron To Begin In February
Human trials of mRNA vaccine against COVID-19's new variant Omicron is to begin from February. Notably, Pune-based Gennova Biopharmaceutical made mRNA vaccine and completed phase I and II trials and submitted a report to the Drugs Controller General of India (DCGI). Along with it, the company also submitted a data of Phase III trials and are waiting for their approval from the Vaccine Subject Expert Committee (SEC).
Tags: mRNA, Omicron Vaccine, Gennova biopharmaceutical, Covid-19, DCGI
Courtesy: The Times Of India
Photo: The Statesman
DCGI Approves India Made RT-PCR Kit To Detect Omicron
The Director Controller General of India (DCGI) approved India made RT-PCR kit to detect new COVID-19 variant "Omicron". On January 5, ICMR General Director Dr Balram Bhagava said, the new RT-PCR kit has been manufactured by Tata MD and ICMR, to test Omicron. "This kit test will give results in four hours," said Dr. Bhagava. Meanwhile, in India, there are a total of 2,135 Omicron cases.
Tags: omicron, DCGI, ICMR, Dr Balram Bhargav, RT-PCR Kit
Courtesy: ANI
Photo: Bharat Biotech Website
DCGI Approves Phase III Trial Of Bharat Biotech's Intranasal COVID-19 Vaccine
The Director Control General of India (DCGI) approved phase III trial of Intranasal COVID-19 vaccine, manufactured by Bharat Biotech. On January 4, the Subject Expert Committee (SEC) of the DCGI, approved the report, following which phase III trail will begin on 5,000 subject, 50% Covishield vaccinated people and 50% COVAXIN vaccinated people. If successful, the Intranasal vaccine will be used as booster shot, especially when nation is facing… read-more
Tags: Bharat biotech, DCGI, Intranasal vaccine, Covid-19, omicron
Courtesy: One India
